BeiGene Ltd - ADR
BGNE
Market Cap$14.94B
Close$
$150.03
2.7% downside
Current Fair Value
2.7% downsideOvervalued by 2.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.94 Billion |
|---|---|
| Enterprise Value | $13.18 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-7.51 |
| Beta | 1.41 |
| Outstanding Shares | 95,687,713 |
| Avg 30 Day Volume | 188,560 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -19.05 |
|---|---|
| PEG | 68.23 |
| Price to Sales | 5.51 |
| Price to Book Ratio | 4.41 |
| Enterprise Value to Revenue | 4.77 |
| Enterprise Value to EBIT | -12 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About BeiGene Ltd
CEO: John Oyler